Enteric Coated, Low- Strength Pancrelipase Formulations

Patent No. EP2621476 (titled "Enteric Coated, Low- Strength Pancrelipase Formulations") was filed by Allergan Pharmaceuticals on Sep 30, 2011. The application was issued on Dec 23, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BASFApr 30, 2015BASF ASSOCIATION

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2621476

ALLERGAN PHARMACEUTICALS
Application Number
EP11788223A
Filing Date
Sep 30, 2011
Status
Patent Maintained As Amended
Jun 19, 2020
Publication Date
Dec 23, 2020